The Lancet. Diabetes and endocrinology

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

NL

tipo

journal

publicação venue de

Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study. 1:1-413. 2023-01-01
Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications. 11:203-216. 2023-01-01
Rare variants in the MECP2 gene in girls with central precocious puberty: a translational cohort study. 11:545-554. 2023-01-01
Burden of diabetes and hyperglycaemia in adults in the Americas, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. 10:00186-3-667. 2022-01-01
Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' reply. 10:98-99. 2022-01-01
Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study. 10:1. 2022-01-01
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. 1:1-16. 2022-01-01
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. 10:869-881. 2022-01-01
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. 10:35-45. 2022-01-01
New metrics to support diabetes education and advocacy. 10:765-766. 2022-01-01
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence - Authors' reply. 10:385-387. 2022-01-01
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT. 10:732-740. 2022-01-01
COVID-19 and metabolic disease: mechanisms and clinical management. 9:786-798. 2021-01-01
Consensus on diagnosis and management of Cushing's disease: a guideline update. 9:847-875. 2021-01-01
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. 09:1-594. 2021-01-01
Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study. 9:7-9. 2021-01-01
Letter to the Editor - Is Non-Alcoholic Fatty Pancreatic Disease a Mechanism of Beta‐cells Dedifferentiation to Trigger Type 2 Diabetes Mellitus?. -:-. 2021-01-01
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature. 9:13-21. 2021-01-01
Thyroid cancer incidence trends by histology in 25 countries: a population-based study. 3:227. 2021-01-01
Bariatric and metabolic surgery during and after the COVID-19 pandemic. 8:741-742. 2020-01-01
Bone mineral density as a surrogate biomarker for fracture risk reduction. 8:875-876. 2020-01-01
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. 8:594-605. 2020-01-01
Metabolic health in Brazil: trends and challenges. 8:937-938. 2020-01-01
Practical recommendations for the management of diabetes in patients with COVID-19. 00:01-05. 2020-01-01
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial. 8:106-114. 2020-01-01
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. 8:773-781. 2020-01-01

tem uma área de assunto

publisher

Elsevier BV

is open access

False invalid format

is in DOAJ

False invalid format